These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17210043)

  • 1. Increased levels of circulating soluble CD14 but not CD83 in infants are associated with early intestinal colonization with Staphylococcus aureus.
    Lundell AC; Adlerberth I; Lindberg E; Karlsson H; Ekberg S; Aberg N; Saalman R; Hock B; Steinkasserer A; Hesselmar B; Wold AE; Rudin A
    Clin Exp Allergy; 2007 Jan; 37(1):62-71. PubMed ID: 17210043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble CD14 and CD83 from human neonatal antigen-presenting cells are inducible by commensal bacteria and suppress allergen-induced human neonatal Th2 differentiation.
    Lundell AC; Andersson K; Josefsson E; Steinkasserer A; Rudin A
    Infect Immun; 2007 Aug; 75(8):4097-104. PubMed ID: 17526743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High circulating immunoglobulin A levels in infants are associated with intestinal toxigenic Staphylococcus aureus and a lower frequency of eczema.
    Lundell AC; Hesselmar B; Nordström I; Saalman R; Karlsson H; Lindberg E; Aberg N; Adlerberth I; Wold AE; Rudin A
    Clin Exp Allergy; 2009 May; 39(5):662-70. PubMed ID: 19302255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota and development of atopic eczema in 3 European birth cohorts.
    Adlerberth I; Strachan DP; Matricardi PM; Ahrné S; Orfei L; Aberg N; Perkin MR; Tripodi S; Hesselmar B; Saalman R; Coates AR; Bonanno CL; Panetta V; Wold AE
    J Allergy Clin Immunol; 2007 Aug; 120(2):343-50. PubMed ID: 17604093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered early infant gut microbiota in children developing allergy up to 5 years of age.
    Sjögren YM; Jenmalm MC; Böttcher MF; Björkstén B; Sverremark-Ekström E
    Clin Exp Allergy; 2009 Apr; 39(4):518-26. PubMed ID: 19220322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergy development and the intestinal microflora during the first year of life.
    Björkstén B; Sepp E; Julge K; Voor T; Mikelsaar M
    J Allergy Clin Immunol; 2001 Oct; 108(4):516-20. PubMed ID: 11590374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of CD14 polymorphisms on the development of soluble CD14 levels during infancy.
    LeVan TD; Guerra S; Klimecki W; Vasquez MM; Lohman IC; Martinez FD; Halonen M; Wright AL
    Genes Immun; 2006 Jan; 7(1):77-80. PubMed ID: 16395394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced levels of soluble CD14 in atopic children.
    Zdolsek HA; Jenmalm MC
    Clin Exp Allergy; 2004 Apr; 34(4):532-9. PubMed ID: 15080804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble CD14 at 2 yr of age: gender-related effects of tobacco smoke exposure, recurrent infections and atopic diseases.
    Lødrup Carlsen KC; Løvik M; Granum B; Mowinckel P; Carlsen KH
    Pediatr Allergy Immunol; 2006 Jun; 17(4):304-12. PubMed ID: 16771785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines and soluble CD14 in breast milk in relation with atopic manifestations in mother and infant (KOALA Study).
    Snijders BE; Damoiseaux JG; Penders J; Kummeling I; Stelma FF; van Ree R; van den Brandt PA; Thijs C
    Clin Exp Allergy; 2006 Dec; 36(12):1609-15. PubMed ID: 17177685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study.
    Morange PE; Tiret L; Saut N; Luc G; Arveiler D; Ferrieres J; Amouyel P; Evans A; Ducimetiere P; Cambien F; Juhan-Vague I;
    Eur J Hum Genet; 2004 Dec; 12(12):1041-9. PubMed ID: 15367917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal microbiota and immunoglobulin E responses in 5-year-old Estonian children.
    Sepp E; Julge K; Mikelsaar M; Björkstén B
    Clin Exp Allergy; 2005 Sep; 35(9):1141-6. PubMed ID: 16164439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD14 polymorphisms and serum CD14 levels through childhood: a role for gene methylation?
    Munthe-Kaas MC; Torjussen TM; Gervin K; Lødrup Carlsen KC; Carlsen KH; Granum B; Hjorthaug HS; Undlien D; Lyle R
    J Allergy Clin Immunol; 2010 Jun; 125(6):1361-8. PubMed ID: 20398919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A promoter polymorphism in the CD14 gene is associated with elevated levels of soluble CD14 but not with IgE or atopic diseases.
    Kabesch M; Hasemann K; Schickinger V; Tzotcheva I; Bohnert A; Carr D; Baldini M; Hackstein H; Leupold W; Weiland SK; Martinez FD; Mutius E; Bein G
    Allergy; 2004 May; 59(5):520-5. PubMed ID: 15080833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levels of the soluble forms of CD80, CD86, and CD83 are elevated in the synovial fluid of rheumatoid arthritis patients.
    Hock BD; O'Donnell JL; Taylor K; Steinkasserer A; McKenzie JL; Rothwell AG; Summers KL
    Tissue Antigens; 2006 Jan; 67(1):57-60. PubMed ID: 16451202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High intestinal IgA associates with reduced risk of IgE-associated allergic diseases.
    Kukkonen K; Kuitunen M; Haahtela T; Korpela R; Poussa T; Savilahti E
    Pediatr Allergy Immunol; 2010 Feb; 21(1 Pt 1):67-73. PubMed ID: 19566584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD14 polymorphisms in mother and infant, soluble CD14 in breast milk and atopy development in the infant (KOALA Study).
    Snijders BE; Stelma FF; Reijmerink NE; Thijs C; van der Steege G; Damoiseaux JG; van den Brandt PA; van Ree R; Postma DS; Koppelman GH
    Pediatr Allergy Immunol; 2010 May; 21(3):541-9. PubMed ID: 19761511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble CD14 in children with status asthmaticus.
    Garty BZ; Monselise Y; Nitzan M
    Isr Med Assoc J; 2000 Feb; 2(2):104-7. PubMed ID: 10804928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between early intestinal colonization, mucosal immunoglobulin A production and systemic immune development.
    Martino DJ; Currie H; Taylor A; Conway P; Prescott SL
    Clin Exp Allergy; 2008 Jan; 38(1):69-78. PubMed ID: 17976218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The differential effect of genetic variation on soluble CD14 levels in human plasma and milk.
    Guerra S; Carla Lohman I; LeVan TD; Wright AL; Martinez FD; Halonen M
    Am J Reprod Immunol; 2004 Sep; 52(3):204-11. PubMed ID: 15373760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.